MedTrace Logo

Comparison Between HA330 Hemoperfusion Filter Hemodialysis and Conventional High-Flux Hemodialysis Filter

NCT05941624 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-05-02

No results posted yet for this study

Summary

The purpose of this study is to compare the effectiveness between conventional hemodialysis and hemodialysis using hemoperfusion adsorbents in renal dysfunction caused by sepsis

Conditions

  • Renal Dysfunction
  • Sepsis
  • Hemodialysis

Interventions

DEVICE

Ha-330 Hemoperfusion Filter Hemodialysis

a total of 4 hours therapy, 3 times a week. Each therapy should be two days apart

DEVICE

Conventional Hemodialysis

a total of 4 hours therapy, 3 times a week. Each therapy should be two days apart

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Dita Aditianingsih, M.D. · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-16
Primary Completion
2023-12-31
Completion
2024-03-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05941624 on ClinicalTrials.gov